60:
29:
156:
The median survival of primary peritoneal carcinomas is usually shorter by 2–6 months time when compared with serous ovarian cancer. Studies show median survival varies between 11.3 and 17.8 months. One study reported 19–40 month median survival (95% CI) with a five-year survival of 26.5%.
460:
441:
76:
is also known as serous surface papillary carcinoma, primary peritoneal carcinoma, extra-ovarian serous carcinoma, primary serous papillary carcinoma, and psammomacarcinoma. It was historically classified under
103:, which include ovarian serous carcinoma, uterine serous carcinoma, fallopian tube serous carcinoma, cervical serous carcinoma, and primary peritoneal serous carcinoma really represent one entity.
392:
Alphs HH, Zahurak ML, Bristow RE, DĂaz-Montes TP (December 2006). "Predictors of surgical outcome and survival among elderly women diagnosed with ovarian and primary peritoneal cancer".
284:
177:
Jaaback KS, Ludeman L, Clayton NL, Hirschowitz L (2006). "Primary peritoneal carcinoma in a UK cancer center: comparison with advanced ovarian carcinoma over a 5-year period".
514:
311:"Phase II Trial of Bevacizumab in Persistent or Recurrent Epithelial Ovarian Cancer or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study"
217:
115:
has been described. Furthermore, women with BRCA1/2 mutation have a 5% risk of developing primary peritoneal cancer even after prophylactic
745:
288:
621:
770:
507:
995:
350:
855:
343:
540:
1044:
1000:
500:
138:
607:
277:
903:
93:, or abdominal cavity. It usually affects women and is diagnosed after the age of 60; it very rarely affects men.
309:
Burger, Robert A.; Sill, Michael W.; Monk, Bradley J.; Greer, Benjamin E.; Sorosky, Joel I. (20 November 2007).
1005:
808:
765:
736:
716:
708:
531:
78:
974:
750:
726:
990:
731:
712:
585:
898:
827:
523:
59:
850:
704:
475:
1039:
788:
557:
880:
668:
630:
740:
351:"New Drug Combination for Ovarian and Primary Peritoneal Cancers - National Cancer Institute"
123:
149:
Prognosis and treatment is the same as for the most common type of ovarian cancer, which is
885:
8:
464:
375:
368:
1065:
945:
927:
867:
696:
692:
354:
261:
236:
198:
252:
1012:
964:
955:
678:
580:
549:
409:
332:
285:"Gynecologic Cancer Treatment—Primary Peritoneal Cancer—Dana-Farber Cancer Institute"
266:
190:
186:
48:
469:
813:
687:
602:
590:
401:
322:
256:
248:
202:
182:
100:
40:
655:
638:
480:
405:
969:
932:
862:
760:
700:
643:
572:
562:
96:
86:
454:
450:
160:
Elevated albumin levels have been associated with a more favorable prognosis.
1059:
913:
595:
492:
327:
310:
112:
134:) as ovarian cancer and can also show an increased expression of HER-2/neu.
28:
875:
413:
336:
270:
194:
116:
111:
Although the precise causes are not known, a link with certain variants of
940:
893:
836:
780:
433:
1026:
150:
90:
36:
922:
845:
663:
380:
985:
53:
176:
445:
82:
391:
982:
131:
127:
81:" (CUP). Primary peritoneal cancer (PPC, or PPCa) is a
99:
and molecular biological characteristics suggest that
423:
122:
Primary peritoneal carcinoma shows similar rates of
308:
237:"The cell of origin of ovarian epithelial tumours"
1057:
522:
508:
43:, which may arise from the peritoneal lining
385:
302:
228:
170:
515:
501:
58:
27:
771:Hereditary nonpolyposis colorectal cancer
326:
260:
996:Intraductal papillary mucinous neoplasm
1058:
234:
496:
215:
1045:Desmoplastic small round cell tumor
13:
746:Polymerase proofreading-associated
139:vascular endothelial growth factor
14:
1077:
608:Hereditary diffuse gastric cancer
216:Type, Cancer (21 February 2022).
106:
904:Nodular regenerative hyperplasia
187:10.1111/j.1525-1438.2006.00474.x
1006:Solid pseudopapillary neoplasm
809:Gastrointestinal stromal tumor
766:Familial adenomatous polyposis
209:
1:
814:Krukenberg tumor (metastatic)
253:10.1016/S1470-2045(08)70308-5
163:
1035:Primary peritoneal carcinoma
709:traditional serrated adenoma
315:Journal of Clinical Oncology
144:
79:carcinoma of unknown primary
22:Primary peritoneal carcinoma
7:
975:Pancreatic ductal carcinoma
406:10.1016/j.ygyno.2006.06.019
218:"Primary peritoneal cancer"
10:
1082:
991:Serous microcystic adenoma
586:Signet ring cell carcinoma
524:Digestive system neoplasia
1025:
954:
912:
899:Focal nodular hyperplasia
835:
826:
801:
779:
677:
654:
629:
620:
571:
548:
539:
530:
427:
70:Primary peritoneal cancer
47:
35:
26:
21:
1001:Mucinous cystic neoplasm
851:Hepatocellular carcinoma
705:sessile serrated adenoma
328:10.1200/JCO.2007.11.5345
1040:Peritoneal mesothelioma
789:Squamous cell carcinoma
558:Squamous cell carcinoma
235:Dubeau, L. (Dec 2008).
179:Int. J. Gynecol. Cancer
881:Hepatocellular adenoma
669:Pseudomyxoma peritonei
181:. 16 Suppl 1: 123–8.
124:tumor suppressor gene
886:Cavernous hemangioma
737:Familial adenomatous
724:Polyposis syndromes:
137:An association with
141:has been observed.
946:Gallbladder cancer
928:Cholangiocarcinoma
868:Liver angiosarcoma
802:Upper and/or lower
751:Serrated polyposis
222:Cancer Research UK
97:Histomorphological
1053:
1052:
1021:
1020:
1013:Pancreatoblastoma
965:exocrine pancreas
822:
821:
797:
796:
616:
615:
581:Gastric carcinoma
490:
489:
376:Peritoneal Cancer
321:(33): 5165–5171.
101:serous carcinomas
67:
66:
16:Medical condition
1073:
833:
832:
732:MUTYH-associated
717:Cronkhite–Canada
688:Colorectal polyp
627:
626:
603:Linitis plastica
591:Gastric lymphoma
546:
545:
537:
536:
517:
510:
503:
494:
493:
425:
424:
418:
417:
389:
383:
372:
366:
365:
363:
362:
353:. Archived from
347:
341:
340:
330:
306:
300:
299:
297:
296:
287:. Archived from
281:
275:
274:
264:
232:
226:
225:
213:
207:
206:
174:
153:ovarian cancer.
63:
62:
41:serous carcinoma
31:
19:
18:
1081:
1080:
1076:
1075:
1074:
1072:
1071:
1070:
1056:
1055:
1054:
1049:
1017:
950:
908:
818:
793:
775:
673:
650:
639:Duodenal cancer
631:Small intestine
612:
567:
526:
521:
491:
486:
485:
436:
422:
421:
390:
386:
373:
369:
360:
358:
349:
348:
344:
307:
303:
294:
292:
283:
282:
278:
233:
229:
214:
210:
175:
171:
166:
147:
109:
57:
17:
12:
11:
5:
1079:
1069:
1068:
1051:
1050:
1048:
1047:
1042:
1037:
1031:
1029:
1023:
1022:
1019:
1018:
1016:
1015:
1009:
1008:
1003:
998:
993:
978:
977:
972:
970:Adenocarcinoma
960:
958:
952:
951:
949:
948:
936:
935:
933:Klatskin tumor
930:
918:
916:
910:
909:
907:
906:
901:
889:
888:
883:
871:
870:
865:
863:Hepatoblastoma
860:
859:
858:
841:
839:
830:
824:
823:
820:
819:
817:
816:
811:
805:
803:
799:
798:
795:
794:
792:
791:
785:
783:
777:
776:
774:
773:
768:
763:
761:Adenocarcinoma
754:
753:
748:
743:
734:
729:
720:
719:
683:
681:
675:
674:
672:
671:
666:
660:
658:
652:
651:
649:
648:
647:
646:
644:Adenocarcinoma
635:
633:
624:
618:
617:
614:
613:
611:
610:
605:
600:
599:
598:
588:
583:
577:
575:
569:
568:
566:
565:
563:Adenocarcinoma
560:
554:
552:
543:
534:
528:
527:
520:
519:
512:
505:
497:
488:
487:
484:
483:
472:
457:
437:
432:
431:
429:
428:Classification
420:
419:
400:(3): 1048–53.
394:Gynecol. Oncol
384:
367:
342:
301:
276:
247:(12): 1191–7.
227:
208:
168:
167:
165:
162:
146:
143:
108:
107:Genetic causes
105:
65:
64:
51:
45:
44:
33:
32:
24:
23:
15:
9:
6:
4:
3:
2:
1078:
1067:
1064:
1063:
1061:
1046:
1043:
1041:
1038:
1036:
1033:
1032:
1030:
1028:
1024:
1014:
1011:
1010:
1007:
1004:
1002:
999:
997:
994:
992:
988:
987:
984:
980:
979:
976:
973:
971:
968:
966:
962:
961:
959:
957:
953:
947:
944:
942:
938:
937:
934:
931:
929:
926:
924:
920:
919:
917:
915:
914:Biliary tract
911:
905:
902:
900:
897:
895:
891:
890:
887:
884:
882:
879:
877:
873:
872:
869:
866:
864:
861:
857:
856:Fibrolamellar
854:
853:
852:
849:
847:
843:
842:
840:
838:
834:
831:
829:
825:
815:
812:
810:
807:
806:
804:
800:
790:
787:
786:
784:
782:
778:
772:
769:
767:
764:
762:
759:
756:
755:
752:
749:
747:
744:
742:
738:
735:
733:
730:
728:
725:
722:
721:
718:
714:
713:Peutz–Jeghers
710:
706:
702:
698:
694:
691:
689:
685:
684:
682:
680:
676:
670:
667:
665:
662:
661:
659:
657:
653:
645:
642:
641:
640:
637:
636:
634:
632:
628:
625:
623:
619:
609:
606:
604:
601:
597:
596:MALT lymphoma
594:
593:
592:
589:
587:
584:
582:
579:
578:
576:
574:
570:
564:
561:
559:
556:
555:
553:
551:
547:
544:
542:
538:
535:
533:
529:
525:
518:
513:
511:
506:
504:
499:
498:
495:
482:
478:
477:
473:
471:
467:
466:
462:
458:
456:
452:
448:
447:
443:
439:
438:
435:
430:
426:
415:
411:
407:
403:
399:
395:
388:
382:
378:
377:
371:
357:on 2010-12-24
356:
352:
346:
338:
334:
329:
324:
320:
316:
312:
305:
291:on 2008-04-29
290:
286:
280:
272:
268:
263:
258:
254:
250:
246:
242:
238:
231:
223:
219:
212:
204:
200:
196:
192:
188:
184:
180:
173:
169:
161:
158:
154:
152:
142:
140:
135:
133:
129:
126:dysfunction (
125:
120:
118:
114:
104:
102:
98:
94:
92:
88:
84:
80:
75:
71:
61:
55:
52:
50:
46:
42:
38:
34:
30:
25:
20:
1034:
981:
963:
939:
921:
892:
874:
844:
757:
723:
697:hyperplastic
686:
679:Colon/rectum
474:
459:
440:
397:
393:
387:
374:
370:
359:. Retrieved
355:the original
345:
318:
314:
304:
293:. Retrieved
289:the original
279:
244:
241:Lancet Oncol
240:
230:
221:
211:
178:
172:
159:
155:
148:
136:
121:
117:oophorectomy
110:
95:
73:
69:
68:
941:gallbladder
894:hyperplasia
89:lining the
1027:Peritoneum
361:2008-05-07
295:2008-05-07
164:References
151:epithelial
91:peritoneum
37:Micrograph
1066:Carcinoma
986:neoplasms
923:bile duct
846:malignant
828:Accessory
758:Neoplasm:
741:Gardner's
664:Carcinoid
550:Esophagus
381:eMedicine
145:Prognosis
74:carcinoma
49:Specialty
1060:Category
956:Pancreas
727:Juvenile
701:juvenile
656:Appendix
532:GI tract
414:16876237
337:18024863
271:19038766
195:16515579
130:, BRCA,
54:Oncology
693:adenoma
573:Stomach
481:D010534
262:4176875
203:2907689
113:BRCA1/2
85:of the
983:cystic
876:benign
412:
335:
269:
259:
201:
193:
83:cancer
56:
837:Liver
622:Lower
541:Upper
455:C48.2
451:C48.1
199:S2CID
87:cells
39:of a
781:Anus
476:MeSH
465:9-CM
410:PMID
333:PMID
267:PMID
191:PMID
470:158
461:ICD
442:ICD
402:doi
398:103
379:at
323:doi
257:PMC
249:doi
183:doi
132:WT1
128:p53
72:or
1062::
989::
715:,
711:,
707:,
703:,
699:,
695:,
479::
468::
449::
446:10
408:.
396:.
331:.
319:25
317:.
313:.
265:.
255:.
243:.
239:.
220:.
197:.
189:.
119:.
967::
943::
925::
896::
878::
848::
739:/
690::
516:e
509:t
502:v
463:-
453:-
444:-
434:D
416:.
404::
364:.
339:.
325::
298:.
273:.
251::
245:9
224:.
205:.
185::
77:"
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
